Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D09JAB
|
||||
Former ID |
DNC012094
|
||||
Drug Name |
3-(2,5-Dioxo-pyrrolidin-1-yl)-benzoic acid
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [1] | ||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C11H9NO4
|
||||
Canonical SMILES |
C1CC(=O)N(C1=O)C2=CC=CC(=C2)C(=O)O
|
||||
InChI |
1S/C11H9NO4/c13-9-4-5-10(14)12(9)8-3-1-2-7(6-8)11(15)16/h1-3,6H,4-5H2,(H,15,16)
|
||||
InChIKey |
BEQRYKGDEGNALQ-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Acetylcholinesterase | Target Info | Inhibitor | [1] | |
KEGG Pathway | Glycerophospholipid metabolism | ||||
Cholinergic synapse | |||||
PANTHER Pathway | Muscarinic acetylcholine receptor 1 and 3 signaling pathway | ||||
Muscarinic acetylcholine receptor 2 and 4 signaling pathway | |||||
Nicotinic acetylcholine receptor signaling pathway | |||||
Pathway Interaction Database | ATF-2 transcription factor network | ||||
PathWhiz Pathway | Phospholipid Biosynthesis | ||||
WikiPathways | Monoamine Transport | ||||
Biogenic Amine Synthesis | |||||
Acetylcholine Synthesis | |||||
Integrated Pancreatic Cancer Pathway | |||||
References | |||||
REF 1 | Bioorg Med Chem Lett. 2003 May 19;13(10):1825-7.Synthesis, anticholinesterase activity and structure-activity relationships of m-Aminobenzoic acid derivatives. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.